Potent FOXO3a Activators from Biologically Active Compound Library for Cancer Therapeutics: An in silico Approach

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• The forkhead transcription factor FOXO3a regulates critical cellular processes like apoptosis and proliferation.
• FOXO3a acts as a tumor suppressor, and its inactivation is linked to cancer development.
• Activating FOXO3a is crucial for reducing and preventing tumorigenesis.

Purpose of the Study:

• To screen for small molecules that can activate FOXO3a using bioinformatics tools.
• To identify novel therapeutic strategies for cancer by targeting FOXO3a.
• To explore potent FOXO3a-activating small molecules for cancer therapeutics.

Main Methods:

• Bioinformatic screening of small molecules targeting FOXO3a.
• Molecular docking simulations to assess binding affinities.
• Molecular dynamic simulations to evaluate the stability of FOXO3a-small molecule complexes.

Main Results:

• Identification of three potent FOXO3a-activating small molecules: F3385-2463, F0856-0033, and F3139-0724.
• These compounds demonstrated significant potential for activating FOXO3a based on computational analyses.
• The identified molecules are candidates for further experimental validation in wet lab settings.

Conclusions:

• The study successfully identified potential FOXO3a-activating small molecules through in silico methods.
• These findings pave the way for developing novel cancer therapeutics aimed at enhancing FOXO3a activity.
• Further experimental validation is warranted to confirm the efficacy of these compounds in cancer treatment.